Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus F Rabe

Showing results (1-10 of 387) with videos related to

Pageof 39
Sort By:
The European Respiratory Journal|April 2, 2015
Treatment of COPD and the TOnado trial: a tempest in a teapot?Klaus F Rabe
American Journal of Respiratory and Critical Care Medicine|May 23, 2002
On theophylline, leukocytes, and chicken soupKlaus F Rabe
American Journal of Respiratory and Critical Care Medicine|November 9, 2018
New Biologics for Severe Asthma: What Patients, What Agents, What Results, at What Cost?Klaus F Rabe
Chest|August 9, 2012
Drug safety in COPD revisited: what is the number needed to analyze?Klaus F Rabe
Proceedings of the American Thoracic Society|April 26, 2006
Improving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategiesKlaus F Rabe
The New England Journal of Medicine|February 23, 2007
Treating COPD--the TORCH trial, P values, and the DodoKlaus F Rabe
Chest|August 5, 2015
Elastic Recoil RevisitedKlaus F Rabe
American Journal of Respiratory and Critical Care Medicine|August 2, 2016
Update in Asthma 2015Klaus F Rabe
Expert Review of Respiratory Medicine|July 24, 2010
Roflumilast for the treatment of chronic obstructive pulmonary diseaseKlaus F Rabe
British Journal of Pharmacology|January 15, 2011
Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseaseKlaus F Rabe
Pageof 39

Showing results (1-10 of 387) with videos related to

Sort By:
Pageof 39
The European Respiratory Journal|April 2, 2015
Treatment of COPD and the TOnado trial: a tempest in a teapot?Klaus F Rabe
American Journal of Respiratory and Critical Care Medicine|May 23, 2002
On theophylline, leukocytes, and chicken soupKlaus F Rabe
American Journal of Respiratory and Critical Care Medicine|November 9, 2018
New Biologics for Severe Asthma: What Patients, What Agents, What Results, at What Cost?Klaus F Rabe
Chest|August 9, 2012
Drug safety in COPD revisited: what is the number needed to analyze?Klaus F Rabe
Proceedings of the American Thoracic Society|April 26, 2006
Improving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategiesKlaus F Rabe
The New England Journal of Medicine|February 23, 2007
Treating COPD--the TORCH trial, P values, and the DodoKlaus F Rabe
Chest|August 5, 2015
Elastic Recoil RevisitedKlaus F Rabe
American Journal of Respiratory and Critical Care Medicine|August 2, 2016
Update in Asthma 2015Klaus F Rabe
Expert Review of Respiratory Medicine|July 24, 2010
Roflumilast for the treatment of chronic obstructive pulmonary diseaseKlaus F Rabe
British Journal of Pharmacology|January 15, 2011
Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseaseKlaus F Rabe
Pageof 39